Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts

Journal of Investigative Dermatology

Volumn 131, Issue 7, 2011, Pages 1469-1476

  Hattori, Tomoyasu ^a   Stawski, Lukasz ^a   Nakerakanti, Sashidhar S ^a   Trojanowska, Maria ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENOMIC DNA; MESSENGER RNA; SMALL INTERFERING RNA; TAMOXIFEN; TRANSCRIPTION FACTOR FLI 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; GENE CONTROL; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN; TREATMENT RESPONSE; WILD TYPE;

EID: 79958859721     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.63     Document Type: Article

References (42)

1. Asano Y, Czuwara J, Trojanowska M (2007) Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/ CREB-binding protein-associated factor-dependent acetylation. J Biol Chem 282:34672-83 (Pubitemid 350232412)
2. Asano Y, Markiewicz M, Kubo M et al. (2009) Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol Cell Biol 29:425-34
3. Asano Y, Stawski L, Hant F et al. (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176:1983-98
4. Asano Y, Trojanowska M (2009) Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta. Mol Cell Biol 29:1882-94
5. Ashcroft GS, Dodsworth J, van Boxtel E et al. (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209-15 (Pubitemid 27508820)
6. Ashcroft GS, Greenwell-Wild T, Horan MA et al. (1999) Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 155:1137-46 (Pubitemid 29488922)
7. Creidi P, Faivre B, Agache P et al. (1994) Effect of a conjugated oestrogen (Premarin) cream on ageing facial skin. A comparative study with a placebo cream. Maturitas 19:211-23 (Pubitemid 24295952)
8. Czuwara-Ladykowska J, Shirasaki F, Jackers P et al. (2001) Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276:20839-48
9. De Servi B, Hermani A, Medunjanin S et al. (2005) Impact of PKCdelta on estrogen receptor localization and activity in breast cancer cells. Oncogene 24:4946-55 (Pubitemid 41129098)
10. deConinck EC, McPherson LA, Weigel RJ (1995) Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cell Biol 15:2191-6
11. Elkareh J, Periyasamy SM, Shidyak A et al. (2009) Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol 296:F1219-26
12. Flouriot G, Brand H, Denger S et al. (2000) Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 19:4688-700
13. Giacomini D, Paez-Pereda M, Stalla J et al. (2009) Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter. Mol Endocrinol 23:1102-14
14. Haczynski J, Tarkowski R, Jarzabek K et al. (2004) Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts. Int J Mol Med 13:903-8
15. Hall G, Phillips TJ (2005) Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol 53:555-68 (Pubitemid 41399920)
16. Hart A, Melet F, Grossfeld P et al. (2000) Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13:167-77
17. Hollenhorst PC, Jones DA, Graves BJ (2004) Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32:5693-702 (Pubitemid 39545685)
18. Ito I, Hanyu A, Wayama M et al. (2010) Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation. J Biol Chem 285:14747-55
19. Jimenez SA, Gaidarova S, Saitta B et al. (2001) Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 108:1395-403 (Pubitemid 33107768)
20. Jinnin M, Ihn H, Mimura Y et al. (2005) Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 33:3540-9 (Pubitemid 41430577)
21. Kos M, Reid G, Denger S et al. (2001) Minireview: genomic organization of the human ERalpha gene promoter region. Mol Endocrinol 15:2057-63 (Pubitemid 33141126)
22. Kubo M, Czuwara-Ladykowska J, Moussa O et al. (2003) Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163:571-81 (Pubitemid 36909419)
23. Kushner PJ, Agard DA, Greene GL et al. (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-7 (Pubitemid 32126243)
24. Matsuda T, Yamamoto T, Muraguchi A et al. (2001) Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 276:42908-14
25. Murphy AJ, Guyre PM, Wira CR et al. (2009) Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One 4:e5539
26. Nabha SM, Glaros S, Hong M et al. (2005) Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells. Oncogene 24:3166-76 (Pubitemid 40695085)
27. Nakerakanti SS, Kapanadze B, Yamasaki M et al. (2006) Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 281: 25259-69 (Pubitemid 44401913)
28. Pannu J, Asano Y, Nakerakanti S et al. (2008) Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum 58:2528-37
29. Pelletier G, Ren L (2004) Localization of sex steroid receptors in human skin. Histol Histopathol 19:629-36 (Pubitemid 38443918)
30. Reid G, Denger S, Kos M et al. (2002) Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell Mol Life Sci 59:821-31 (Pubitemid 34628243)
31. Rittie L, Kang S, Voorhees JJ et al. (2008) Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo. Arch Dermatol 144:1129-40
32. Sakthianandeswaren A, Curtis JM, Elso C et al. (2010) Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun 78:2734-44
33. Saville B, Wormke M, Wang F et al. (2000) Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-87 (Pubitemid 30115168)
34. Shirasaki F, Makhluf HA, LeRoy C et al. (1999) Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18:7755-64 (Pubitemid 30052760)
35. Soldano S, Montagna P, Brizzolara R et al. (2010) Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Ann NY Acad Sci 1193:25-9
36. Spyropoulos DD, Pharr PN, Lavenburg KR et al. (2000) Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 20:5643-52 (Pubitemid 30482898)
37. Surazynski A, Jarzabek K, Haczynski J et al. (2003) Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Mol Med 12:803-9
38. Thornton MJ, Taylor AH, Mulligan K et al. (2003) Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 12:181-90 (Pubitemid 36939119)
39. Varila E, Rantala I, Oikarinen A et al. (1995) The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 102:985-9 (Pubitemid 26014994)
40. Wang Z, Zhang X, Shen P et al. (2005) Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun 336:1023-7 (Pubitemid 41383424)
41. Yamamoto T, Saatcioglu F, Matsuda T (2002) Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology 143:2635-42 (Pubitemid 34701327)
42. Yoo HG, Won CH, Lee SR et al. (2007) Expression of androgen and estrogen receptors in human scalp mesenchymal cells in vitro. Arch Dermatol Res 298:505-9 (Pubitemid 46295058)